Kindeva Drug Delivery

Bronze Sponsor

Information

Kindeva Drug Delivery is a CDMO offering its partners integrated, end-to-end capabilities spanning formulation, product development, scale-up manufacturing, and commercial manufacturing. Its full-service innovation offering covers inhalation (pMDIs, DPIs, connectivity, nasal delivery); transdermal delivery (drug-in-adhesive systems, membrane systems, reservoir systems, gel patches); and intradermal delivery (microneedles based on solid and hollow microstructures). Kindeva Drug Delivery has locations in the US and the UK and employs 900 people.

Profile
Contract ManufacturingEquipment & Device Manufacturers

Social media

Contact details

+1 612 889 5231
+1 800 643 8086
contactus@kindevadd.com
www.kindevadd.com
Saint Paul
Saint Paul, Minnesota, United States

Products & Services

Sessions

Cancer vaccine delivery by precise intradermal administration

Thursday, October 1, 2020 8:20 PM to 8:50 PM

Documents & Links

Kindeva: A Historic CDMO RebornOur name has changed, but Kindeva remains the world’s foremost CDMO in guiding customers through complex drug formulation and delivery.
Let us help you take on cancer.Powerful cancer vaccines are one part of the cancer treatment puzzle. Kindeva's hMTS is designed to help.
Addressing the Challenges of Vaccines and Interdermal DeliveryThis article considers six shortcomings in the way vaccines are developed and delivered. Addressing these deficiencies could improve your vaccines.
Coated microneedles for transdermal delivery of a potent pharmaceutical peptideMinimally invasive delivery of peptide and protein molecules represents an opportunity for differentiation and value vs standard injectables.
Challenges of drug delivery with Kindeva Drug DeliveryEPM speaks to Kirsty Gapp, Kindeva Drug Delivery about the challenges and trends within the industry and why interest in microneedle technology is surging.

Log in